Nevertheless, it remains unknown whether CXCR4-mediated signaling in ovarian cancer is involved in PI3K/Akt/mTOR pathway regulation and impacts EMT and CSC characteristics, invasion and metastasis. This evidence concerns the gene AKT1 and ovarian carcinoma.